Global Cord Blood (CORBF) Competitors $1.06 +0.01 (+0.95%) As of 04/30/2025 03:07 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CORBF vs. TALK, SBC, CELC, EHAB, INNV, PSNL, VMD, LFMD, DCGO, and TOIShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Talkspace (TALK), SBC Medical Group (SBC), Celcuity (CELC), Enhabit (EHAB), InnovAge (INNV), Personalis (PSNL), Viemed Healthcare (VMD), LifeMD (LFMD), DocGo (DCGO), and Oncology Institute (TOI). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Talkspace SBC Medical Group Celcuity Enhabit InnovAge Personalis Viemed Healthcare LifeMD DocGo Oncology Institute Global Cord Blood (NYSE:CORBF) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Which has better earnings & valuation, CORBF or TALK? Global Cord Blood has higher revenue and earnings than Talkspace. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.66$79.04MN/AN/ATalkspace$187.59M2.81-$19.18M$0.01313.00 Do analysts recommend CORBF or TALK? Talkspace has a consensus price target of $4.50, suggesting a potential upside of 43.77%. Given Talkspace's stronger consensus rating and higher probable upside, analysts clearly believe Talkspace is more favorable than Global Cord Blood.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more risk and volatility, CORBF or TALK? Global Cord Blood has a beta of -0.64, suggesting that its stock price is 164% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Does the MarketBeat Community favor CORBF or TALK? Talkspace received 6 more outperform votes than Global Cord Blood when rated by MarketBeat users. CompanyUnderperformOutperformGlobal Cord BloodN/AN/ATalkspaceOutperform Votes642.86% Underperform Votes857.14% Do insiders & institutionals believe in CORBF or TALK? 57.4% of Talkspace shares are held by institutional investors. 0.5% of Global Cord Blood shares are held by insiders. Comparatively, 21.7% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is CORBF or TALK more profitable? Talkspace has a net margin of 0.61% compared to Global Cord Blood's net margin of 0.00%. Talkspace's return on equity of 0.98% beat Global Cord Blood's return on equity.Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Talkspace 0.61%0.98%0.84% Does the media prefer CORBF or TALK? In the previous week, Talkspace had 6 more articles in the media than Global Cord Blood. MarketBeat recorded 6 mentions for Talkspace and 0 mentions for Global Cord Blood. Talkspace's average media sentiment score of 1.49 beat Global Cord Blood's score of 0.00 indicating that Talkspace is being referred to more favorably in the news media. Company Overall Sentiment Global Cord Blood Neutral Talkspace Positive SummaryTalkspace beats Global Cord Blood on 14 of the 16 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$128.84M$1.98B$5.53B$18.96BDividend YieldN/A7.12%5.11%4.01%P/E RatioN/A15.9322.5132.87Price / Sales0.663.76397.6228.03Price / Cash1.409.3238.1817.52Price / BookN/A3.986.734.47Net Income$79.04M$87.49M$3.22B$1.02B7 Day Performance0.95%-0.88%1.38%0.59%1 Month Performance0.95%-7.02%2.79%-3.54%1 Year Performance-15.20%-27.54%15.41%3.80% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$1.06+1.0%N/AN/A$128.84M$196.12M0.001,200Gap UpTALKTalkspace3.9741 of 5 stars$2.58-3.4%$4.50+74.4%-0.9%$434.57M$187.59M258.26500Upcoming EarningsPositive NewsSBCSBC Medical GroupN/A$4.11+2.2%N/AN/A$425.84M$205.42M0.00N/AGap UpCELCCelcuity2.6444 of 5 stars$10.45+2.1%$30.17+188.7%-33.7%$395.42MN/A-4.0040Short Interest ↓Analyst RevisionNews CoverageEHABEnhabit1.5476 of 5 stars$7.24-5.7%$8.50+17.4%-22.8%$365.48M$1.03B-3.1210,900Upcoming EarningsNews CoveragePositive NewsINNVInnovAge1.3841 of 5 stars$2.67-2.9%$5.00+87.3%-23.2%$361.10M$806.61M-14.052,000Upcoming EarningsNews CoverageGap DownPSNLPersonalis3.6262 of 5 stars$3.16-0.9%$7.80+146.8%+149.0%$279.05M$84.61M-1.88400Upcoming EarningsNews CoverageVMDViemed Healthcare1.7505 of 5 stars$6.61-0.3%N/A-15.4%$261.24M$224.26M24.48630Upcoming EarningsShort Interest ↓Positive NewsLFMDLifeMD2.4098 of 5 stars$5.39-0.7%$11.43+112.0%-36.1%$240.31M$212.45M-8.42230Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownDCGODocGo2.5149 of 5 stars$2.07-2.4%$4.89+136.3%-35.1%$211.11M$616.56M7.392,920Upcoming EarningsPositive NewsTOIOncology Institute0.8102 of 5 stars$2.39+10.6%N/A+149.1%$180.59M$393.41M-3.06660News Coverage Related Companies and Tools Related Companies TALK Competitors SBC Competitors CELC Competitors EHAB Competitors INNV Competitors PSNL Competitors VMD Competitors LFMD Competitors DCGO Competitors TOI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CORBF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
